Pluto Health is a technology company.
Pluto Health has raised $3.0M across 1 funding round.
Pluto Health has raised $3.0M in total across 1 funding round.
Pluto Health has raised $3.0M in total across 1 funding round.
Pluto Health's investors include Afore Capital, America's Frontier Fund, Flybridge Capital Partners, The House Fund.
Pluto Health is a Duke University spin-out technology company that builds an AI-enabled platform unifying fragmented health data from ~90% of US health systems, including EMRs, labs, claims, and social determinants of health (SDOH), to identify care gaps and deliver personalized resources like preventive care, at-home labs, cancer screenings, vaccines, and clinical trial pre-screening[1][2][3]. It serves payors (e.g., Medicare, Medicaid, UnitedHealthcare, Aetna, Blue Cross Blue Shield, Ambetter, Cigna), clinicians, health systems, life sciences, and communities, solving the problem of siloed data that delays interventions by providing clinical intelligence, personalized treatment plans, and last-mile care delivery in patients' homes[1][4][7]. The company has shown strong growth momentum, including TIME's 2025 World's Top HealthTech Companies recognition, payer expansions in 2025, and scaling AI models across cardiometabolic, oncology, and women's health domains by 2027[3][4].
Pluto Health launched in 2020 as a spin-out from Duke University, founded by Dr. Joy Bhosai, MD, MPH, who serves as CEO and brings expertise in clinical care, AI, and data science to address fragmented healthcare data[3][4][7]. The idea emerged from Bhosai's vision to restore "humanity and lost patient care time" in healthcare by combining smart technology with actionable care delivery, starting with data unification to enable faster, smarter decisions without patient recall[1][3]. Early traction included partnerships with health systems for gap closure and recognition under Medicaid Tennessee, evolving into payer expansions with major commercial plans in 2025 and TIME's top HealthTech accolade[2][4][7].
Pluto Health rides the wave of AI-powered digital health interoperability and value-based care, where fragmented data silos hinder preventive interventions amid rising chronic disease burdens and payer demands for quality metrics[1][2][4]. Timing is ideal post-2020 amid TEFCA and HITRUST advancements, enabling seamless data exchange while competitors like Health Gorilla focus on APIs and Bamboo Health on ADT networks—Pluto uniquely closes the loop with delivery[2][6]. Market forces like payer shifts to Medicare/Medicaid expansions and home-based care post-pandemic favor its model, reducing costs and readmissions for underserved patients with chronic conditions[4][7]. It influences the ecosystem by setting a standard for "clinical intelligence + care delivery," bridging payors, providers, and life sciences to foster equitable access[1][3].
Pluto Health is poised to dominate AI-orchestrated care navigation, expanding its closed-loop platform with refined personalized AI models targeting high-need domains like oncology and cardiometabolic health through 2027[3]. Trends in home-based services, payer accountability, and multimodal data (including wearables) will accelerate its growth, potentially capturing larger shares of the $11,000+ digital health market via deeper payer embeds[2][4]. Its influence may evolve from gap-closer to full-spectrum care coordinator, powering systemic equity—unifying data to not just identify needs, but deliver the right care faster and smarter, as its mission promises[1][3].
Pluto Health has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in November 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2020 | $3.0M Seed | Afore Capital, America's Frontier Fund, Flybridge Capital Partners, The House Fund |